Navigation Links
NeurogesX Reports Third Quarter 2008 Results
Date:11/6/2008

pectively. The weighted average shares used in computing loss per share attributable to common stockholders exclude anti-dilutive securities such as stock options and warrants.

Cash, cash equivalents and short-term investments were approximately $30.8 million as of September 30, 2008, compared to $38.0 million at June 30, 2008.

Stephen Ghiglieri, CFO, commented, "In this difficult financial market, we are dedicating our financial resources primarily to obtain marketing approvals for NGX-4010. By pursuing this focused strategy, we believe our existing cash resources are sufficient to move us through expected regulatory decisions in both the U.S. and Europe, and potentially into early 2010. Our objective is to ensure an effective launch of NGX-4010, if approved, in both Europe and the United States. We intend to achieve this through effective cost management, including a near-term focus on activities for NGX-4010 that support the ongoing regulatory review processes and our reimbursement strategies and through commercial partnerships and other non-equity sources of funding. In addition, we anticipate that these other sources of funding could create opportunities to more rapidly advance our development initiatives in addition to effectively launching NGX-4010 in the United States. Given the current state of the equity markets, we have no current intention to raise equity capital in the public markets."

Clinical Development Update

NeurogesX' near-term clinical focus is to secure regulatory approvals of the NDA and MAA for NGX-4010. Regarding the potential for additional clinical studies in HIV-DSP and/or PDN, NeurogesX continues to evaluate the appropriate scope and nature of future studies, if any, in these indications. The timing for initiating such studies will be based in part on availability of financial resources.

NGX-1998, the Company's second-generation, liquid formulation of high-concentration capsaicin (10% trans-capsaicin) is
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
2. NeurogesX Appoints New Director to the Board
3. NeurogesX to Present at UBS 2007 Global Life Sciences Conference
4. NeurogesX Expands Senior Management Team
5. NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. NeurogesX to Present at Lazard Capital Markets Healthcare Conference
7. NeurogesX, Inc. Announces $25 Million Private Placement
8. NeurogesX Closes $25 Million Private Placement
9. NeurogesX to Present at the 10th Annual BIO CEO & Investor Conference
10. NeurogesX to Present at Roth 2008 OC Growth Stock Conference
11. NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 Look inside ... hard-working items for the lab, from fluid handling to ... (GIS)—ready to ship when you order. , Preferred ... Pumps , from the L/S® model for precise flow ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 This webinar ... nonclinical and clinical safety assessment in biosimilars. , Regulatory ... for biosimilar drug development, however the complex nature of ... quality, safety and efficacy extremely challenging. Based on the ...
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA theory ... of these latent viruses is the Epstein Barr Virus (EBV), ... arthritis (RA) is a chronic inflammatory disease that destroys the ... that RA patients have high concentrations of EBV DNA in ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider ... treatment of tinnitus. Patients listen to sound therapy that ... period of weeks to months, their tinnitus volume decreases. , ... Notched Music and Notched White Noise. Now, AudioNotch is pleased ...
Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... be challenged by the intervention of California Governor Arnold ... Bush administration, whose campaign he supports, Schwarzenegger announced on ... Proposition 71 , a California initiative on the ... the sale of $3 billion in bonds, and lay ...
... owns worldwide make batteries, lights and personal grooming products, ... other products. The company employs about 5,000 people. Ben ... engineer Mike Gutknecht; Brent Leland, director of business IT; ... effect of Sarbanes-Oxley on IT processes, myths about ROI ...
... in Wisconsin Rapids, will lead an interstate effort to ... Governor Jim Doyle has announced. , ,The college will ... National Science Foundation, some of which will fund a ... money will also help launch a national training network ...
Cached Biology Technology:Stem-cell support from Schwarzenegger could shake Wisconsin leadership 2Stem-cell support from Schwarzenegger could shake Wisconsin leadership 3Stem-cell support from Schwarzenegger could shake Wisconsin leadership 4Rayovacs IT team discusses network security, Sarbanes-Oxley and ROI myths 2Rayovacs IT team discusses network security, Sarbanes-Oxley and ROI myths 3Rayovacs IT team discusses network security, Sarbanes-Oxley and ROI myths 4Rayovacs IT team discusses network security, Sarbanes-Oxley and ROI myths 5Wisconsin to train tech-savvy paper industry with share of $5 million grant 2
(Date:4/23/2014)... A biomedical engineer at the University of Houston ... make blood transfusions safer. His work is supported by ... Health (NIH). , Blood transfusions save millions of ... absolute necessities. Without them, for instance, routine surgeries would ... however. There,s strong evidence that transfusions of red blood ...
(Date:4/23/2014)... used to read quickly. It involves visual searching ... and/ or sentences. Similarly to humans, biological systems ... genetic information. Genes that need to be read ... encoding message, the easier it will be to ... de Cincia (IGC, Portugal) and Centre for Molecular ...
(Date:4/23/2014)... one can argue that if we were to follow a ... we canthen we can solve the climate problem without doing ... climate researchers, in the current issue of Bulletin of ... significant action on climate change now makes it more likely ... Wigley explains in an exclusive Bulletin interview. ...
Breaking Biology News(10 mins):UH biomedical engineer works to make blood transfusions safer 2UH biomedical engineer works to make blood transfusions safer 3Cell division speed influences gene architecture 2Is nuclear power the only way to avoid geoengineering? 2
... fundamental building block of nearly all living material: carbon. ... for bacteria. Methane is produced in oxygen-free environments and ... The Brazilian post-doctoral researcher in biology and ecology, Angela ... lakebeds to be present in fish tissue. The study ...
... This release is available in German . Vitamin ... cells and the functioning of the nervous system. Unable to produce ... animal proteins. So far it has been known that on its ... so-called lysosomes. From there, the vitamin enters the cell interior with ...
... CITY, MOTwo opposing teams battle it out to regulate ... activators, keeps DNA open to enzymes that transcribe DNA ... twisting DNA into an inaccessible coil around histone proteins, ... by enzymes that elongate an RNA strand. Both ...
Cached Biology News:How methane becomes fish food 2Vitamin B12 deficiency: Tracing the causes 2Controlling gene expression: How chromatin remodelers block a histone pass 2Controlling gene expression: How chromatin remodelers block a histone pass 3
Human peripheral blood basophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Umbilical cord blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Human peripheral blood neutrophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
... has been developed specifically for the ... on microwell plates/strips. Coating Stabilizer ... the antibody or protein antigen portion ... Product is filtered at 0.2 microns., ...
Biology Products: